Registration is now open for the Brain Products Academy webinar Design effective trigger codes for your EEG study taking place on October 23, 2025!
A recording of the recent Brain Products Academy workshop on Integrating EEG & neuronavigated TMS is now available on the Brain Products YouTube channel.
Despite the advanced treatment options available, chronic wounds continue to pose a challenge in therapy. They often heal only incompletely and are susceptible to infection. Against this background, Extracorporeal Shock Wave Therapy (ESWT) has increasingly formed the focus of research
According to the World Health Organization (WHO), musculoskeletal conditions affect more than 1.7 billion people worldwide.
The Advanced Neuromodulation and Neuromonitoring Training Workshop 2025 by Soterix Medical is focused on fundamentals and advanced applications of non-invasive neuromodulation and neuromonitoring technologies including conventional and High Definition transcranial Direct Current Stimulation (tDCS/HD-tDCS), Transcranial Magnetic Stimulation (TMS), transcranial Focused Ultrasound Stimulation (tFUS), Interferential Stimulation (IFS), transcranial Photobiomodulation (PBM), Galvanic Vestibular Stimulation (GVS), transcutaneous Auricular Vagus Nerve Stimulation (taVNS), and closed-loop transcranial Electrical Stimulation (tES) and monitoring (EEG, fNIRS, etc.).
We are excited to announce that Longship Fund III has invested in NordicNeuroLab, becoming the majority owner of the company. This marks the beginning of a new and promising chapter for NordicNeuroLab, with a strong focus on growth, international expansion, and continued innovation in advanced MRI solutions.
Functional MRI (fMRI) has become one of the most powerful tools in neuroscience and clinical practice. It enables us to map brain activity, support risk assessment and surgical planning, and explore the mechanisms behind neurological and psychiatric conditions.
Thank you to all who joined us in Phoenix for this year’s Noraxon User Group Meeting! We had an incredible two days of learning, collaboration, and conversation with clinicians, researchers, and performance specialists from across the biomechanics community.
Approximately 30% of U.S. adolescents diagnosed with major depressive disorder (MDD) do not respond to standard treatments and meet criteria for treatment-resistant depression (TRD). Transcranial Magnetic Stimulation (TMS) is considered a safe and effective treatment option for adolescents with Major Depressive Disorder.
Places are limited, so be sure to book early for the 2026 sessions.